Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
70.2 CHF | -1.54% |
|
0.00% | +37.72% |
Jun. 18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
Jun. 03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.72% | 1.28B | |
+61.53% | 848B | |
+33.56% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+12.02% | 234B | |
+16.08% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cassiopea Gets SIX Swiss Exchange Nod to Delist After Cosmo Pharmaceuticals Buyback